Developing the analytics and analytical workflows supporting the analysis of the next generation of biotherapeutic and gene therapies
Prezentace | 2020 | WatersInstrumentace
Spotřební materiál, Iontová mobilita, HPLC, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, LC kolony, LC/SQ
ZaměřeníFarmaceutická analýza, Proteomika, Klinická analýza
VýrobceWaters
Klíčová slovacapsid, aav, empty, development, gene, protein, capsids, therapy, sec, proteins, full, monitoring, iex, rplc, measure, characterization, vector, bioaccord, biopharmaceutical, arc, emerson, waldo, auc, viral, challenges, flr, virus, peptide, mass, profile, native, identity, purity, difference, analysis, formulated, acquity, mapping, ratio, bio, surfactant, ims, attribute, analytical, routine, class, separation, batch, late, ralph
Podobná PDF
Optimizing Adeno-Associated Virus (AAV) Capsid Protein Analysis Using UPLC and UPLC-MS
2020|Waters|Aplikace
[ APPLICATION NOTE ] Optimizing Adeno-Associated Virus (AAV) Capsid Protein Analysis Using UPLC and UPLC-MS Ximo Zhang, Stephan Koza, Ying Qing Yu, and Weibin Chen Waters Corporation, Milford, MA, USA APPLICATION BENEFITS ■ ■ INTRODUCTION An optimized LC-MS solution for…
Klíčová slova
capsid, capsidaav, aavadeno, adenouplc, uplcvirus, virusassociated, associatedproteins, proteinsoptimizing, optimizingraav, raavmass, massflr, flrtherapy, therapygene, geneacquity, acquityprotein
Waters VIZE: Nové léčebné terapie a jejich analytika
2021|Waters|Prezentace
Nové léčebné terapie a jejich analytika Jak pandemie urychlila vývoj genových terapií Martin Gilar 23. 11. 2021, Vize 2021 Příslib genových terapií ▪ Známe generický kód - můžeme léčit jakoukoliv nemoc ▪ Obecný mechanismus - specifický DNA cíl ▪ Nejen…
Klíčová slova
confidential, confidentialcuc, cucucu, ucuuuc, uuccompany, companyaau, aauugu, uguuug, uugmrna, mrnabuněk, buněkatt, attterapie, terapieterapií, terapiígenové, genovéoligonucleotides
Advanced Therapeutic Medicinal Products: Adeno-associated Virus (AAV)
2021|Waters|Ostatní
Advanced Therapeutic Medicinal Products: Adeno-associated Virus (AAV) The Promise of Viral Vector Gene Therapy using AAV 7000 Monogenic Diseases 20 of 22 4 Years Children with spinal muscular atrophy (SMA) given the ability to thrive with Zolgensma® (AAV) at 91%…
Klíčová slova
aav, aavglossary, glossarybioprocess, bioprocesscapsid, capsidmapping, mappingdiscovery, discoverygene, generegulatory, regulatorydevelopment, developmentspecifications, specificationstherapy, therapyvirus, virusadeno, adenoviral, viraltransduction
Characterizing AAVs
2023|Waters|Příručky
CONSUMABLES GUIDE BOOK Characterizing AAVs Chromatographic methods to measure heterogeneity and critical quality attributes CONSUMABLES GUIDE BOOK A Changing Industry Attribute Testing The advent of FDA approved gene therapies brings An AAV vectored therapy contains multiple types of biomolecules compromised…
Klíčová slova
aav, aavprotein, proteincapsid, capsidtransgene, transgenebook, bookaex, aexpak, pakencapsidation, encapsidationgenome, genomecolumn, columnpotency, potencyrplc, rplcdiameter, diameterpeptide, peptideempty
